NCT01724242

Vaginal DHEA for Women After Breast Cancer

Vaginal DHEA to Ease Vaginal Dryness in Women With a Contraindication to Estrogen Therapy

• Status: Withdrawn
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Hadassah Medical Organization · Academic / Other
• Sex: Female
• Age: 35 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

There does not appear to be a consensus regarding the treatment of vaginal dryness in women who have a contraindication to the use of estrogen products. DHEA, when used locally, may improve the symptoms of vaginal dryness due to its chemical properties.

Conditions

• Vaginal Dryness
• Breast Cancer
• Urinary Incontinence
• Quality of Life
• Sexual Satisfaction

Interventions

Type	Name	Description
DRUG	Vaginal DHEA
DRUG	Placebo

Timeline

• Start date: 2013-02-01
• Primary completion: 2014-01-01
• Completion: 2014-12-01
• First posted: 2012-11-09
• Last updated: 2017-11-28

Locations

1 site across 1 country: Israel